Anggaya, Riley .
HRN: 25-65-73 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/29/2025
OXACILLIN 500MG (VIAL)
01/29/2025
02/04/2025
IV
300mg
Q6h
Cellulitis
Waiting Final Action
04/24/2025
CEFUROXIME 750MG (VIAL)
04/24/2025
05/01/2025
IV
350mg
Q8h
PCAP C
Waiting Final Action